Neogenomics Inc
NEO- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001077183
No open-market purchases or sales by Neogenomics Inc insiders were filed in the last 90 days; 266 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $2.28B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +17 vs. previous quarter
- 266
- 13F valueReported value at the end of Q2 2026
- $2.11B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $727.3M
- +10.1% year over year
- Net income, FY2025
- -$108.0M
- No comparable prior period
- Free cash flow, FY2025
- -$21.8M
- No comparable prior period
- Revenue, Q3 FY2026
- $209.3M
- +11.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $108.0M (14.9% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 14.2M
- Shares sold short
- Change
- +64.6K
- +0.5% vs. previous
- Days to cover
- 6.03
- At average daily volume
Superinvestors holding NEO, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding NEO at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Neogenomics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 (view filing)4:02 PM ET | Aug 4 | 2 days | Aunan Greg DChief Accounting Officer | SSale | −20.0K | $16.07 | −$321.4K | −79.5%5.15K after | |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Tetrault Lynn A.Director | SSale | −5.31K | $11.10 | −$58.9K | −5.8%86.1K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 9 | 2 days | Tetrault Lynn A.Director | SSale | −5.31K | $11.29 | −$59.9K | −5.5%91.4K after | 10b5-1 |
| Jan 21, 2026 (view filing) | Jan 20 | 1 day | Stone WarrenPres & Chief Operating Officer | SSale | −22.1K | $12.50 | −$276.6K | −15.4%121.6K after | 10b5-1 |
| Nov 28, 2025 (view filing) | Nov 25 | 3 days | Olivo Alicia CEVP, GC & Business Development | SSale | −20.9K | $12.00 | −$251.0K | −40.2%31.1K after | 10b5-1 |
| Oct 20, 2025 (view filing) | Oct 16 | 4 days | Olivo Alicia CEVP, GC & Business Development | SSale | −4.92K | $10.00 | −$49.2K | −10.3%43.0K after | 10b5-1 |
| Aug 6, 2025 (view filing) | Aug 6 | Same day | Sherman Jeffrey ScottChief Financial Officer | PPurchase | +20.0K | $5.62 | +$112.4K | +11.9%188.3K after | |
| Aug 6, 2025 (view filing) | Aug 6 | Same day | Zook Anthony P.Chief Executive Officer | PPurchase | +17.9K | $5.58 | +$99.9K | +88.8%38.1K after | |
| May 28, 2025 (view filing) | May 27 | 1 day | Kelly Michael AaronDirector | PPurchase | +5.00K | $7.60 | +$38.0K | New position5.00K after | |
| May 13, 2025 (view filing) | May 12 | 1 day | Stone WarrenPres & Chief Operating Officer | PPurchase | +5.70K | $8.58 | +$48.9K | +5.6%108.3K after |
Top 10 13F holders, Q2 2026
See all 266 holdersThe largest institutional positions in Neogenomics Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20,868,362 | $304.5M | 0.00% | +910,860+4.6% | Added |
| First Light Asset Management, LLC | 12,279,523 | $179.2M | 10.89% | +2,549,545+26.2% | Added |
| First Trust Advisors LP | 10,113,261 | $147.6M | 0.09% | +3,950,890+64.1% | Added |
| Greenhouse Funds LLLP | 8,574,210 | $125.1M | 6.59% | −525,893−5.8% | Reduced |
| Vanguard Portfolio Management LLC | 8,061,362 | $117.6M | 0.01% | +439,175+5.8% | Added |
| Vanguard Capital Management LLC | 5,763,017 | $84.1M | 0.00% | +107,194+1.9% | Added |
| State Street Corp | 5,363,784 | $78.3M | 0.00% | +243,946+4.8% | Added |
| Nomura Asset Management International Inc. | 5,037,787 | $73.5M | 0.11% | +1,585,200+45.9% | Added |
| Braidwell LP | 4,918,202 | $71.8M | 2.65% | −699,200−12.4% | Reduced |
| Schroder Investment Management Group | 4,342,883 | $61.9M | 0.04% | +774,305+21.7% | Added |
Holders of 5% or more of NEO
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Neogenomics Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.60%20.4M shares | +1.00 ppfrom 14.60% | Oct 17, 20252 filings | Jul 30, 2026 | SEC |
| First Light Asset Management, LLC | 13G/A | 8.37%10.8M shares | −2.45 ppfrom 10.82% | Aug 14, 20253 filings | Aug 14, 2026 | SEC |
| First Trust Portfolios LP | 13G | 7.77%10.1M shares | New | Jul 30, 20261 filing | Jul 30, 2026 | SEC |
| Greenhouse Funds LLLP | 13G/A | 7.10%9.22M shares | +1.30 ppfrom 5.80% | Aug 13, 20252 filings | May 15, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.91%7.68M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Politician trades
All politician trades in NEO4 members of Congress reported 6 trades in Neogenomics Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 10, 2026 |  Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Jun 6, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Apr 25, 2022 |  Dwight Evans House · PA | Sell | $1K-$15K |
| Jan 8, 2022 |  Deborah K. Ross House · NC | Buy | $15K-$50K |
| Nov 14, 2021 |  Bob Gibbs House · OH | Sell | $1K-$15K |
House · CA · Sep 10, 2026
Buy$1K-$15K
House · CA · Jun 6, 2025
Buy$1K-$15K
House · PA · Apr 25, 2022
Sell$1K-$15K
House · NC · Jan 8, 2022
Buy$15K-$50K
House · OH · Nov 14, 2021
Sell$1K-$15K